The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Mayr, E. (1963) · doi:10.4159/harvard.9780674865327 · Cited by 10,175
Falush, D., Stephens, M., & Pritchard, J. K. (2003) · Genetics · doi:10.1093/genetics/164.4.1567 · Cited by 7,959
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
Carey, L. A., Perou, C. M., Livasy, C. A., Dressler, L. G., Cowan, D., Conway, K., Karaca, G., Troester, M. A., Tse, C. K., Edmiston, S., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2492 · Cited by 3,819
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Beighton, P., & Beighton, G. (1997) · The Person Behind the Syndrome · doi:10.1007/978-1-4471-0925-9_118 · Cited by 3,159
Mitochondrial DNA and human evolution
Cann, R. L., Stoneking, M., & Wilson, A. C. (1987) · Nature · doi:10.1038/325031a0 · Cited by 3,100
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301749 · Cited by 3,037
The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews
Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,281
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
King, M.-C., Marks, J. H., & Mandell, J. B. (2003) · Science · doi:10.1126/science.1088759 · Cited by 2,229
Genetic Structure of Human Populations
Rosenberg, N. A., Pritchard, J. K., Weber, J. L., Cann, H. M., Kidd, K. K., Zhivotovsky, L. A., & Feldman, M. W. (2002) · Science · doi:10.1126/science.1078311 · Cited by 2,222
Risks of cancer in BRCA1-mutation carriers
FORD, D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91578-4 · Cited by 1,850
Gene-Expression Profiles in Hereditary Breast Cancer
Hedenfalk, I., Duggan, D., Chen, Y., Radmacher, M., Bittner, M., Simon, R., Meltzer, P., Gusterson, B., Esteller, M., Raffeld, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102223440801 · Cited by 1,733
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
Easton, D. F., Ford, D., & Bishop, D. T. (1995) · PubMed Central · Cited by 1,602
Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations
Rebbeck, T. R., Lynch, H. T., Neuhausen, S. L., Narod, S. A., van't Veer, L., Garber, J. E., Evans, G., Isaacs, C., Daly, M. B., Matloff, E., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012158 · Cited by 1,465
Self-citationPhenotypic evaluation of the basal-like subtype of invasive breast carcinoma
Livasy, C. A., Karaca, G., Nanda, R., Tretiakova, M. S., Olopade, O. I., Moore, D. T., & Perou, C. M. (2006) · Modern Pathology · doi:10.1038/modpathol.3800528 · Cited by 1,063
Self-citationRisch, H. A., McLaughlin, J. R., Cole, D. E. C., Rosen, B., Bradley, L., Kwan, E., Jack, E., Vesprini, D. J., Kuperstein, G., Abrahamson, J. L. A., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318787 · Cited by 986
CTLA-4: new insights into its biological function and use in tumor immunotherapy
Egen, J. G., Kuhns, M. S., & Allison, J. P. (2002) · Nature Immunology · doi:10.1038/ni0702-611 · Cited by 940
Genetic analysis of breast cancer in the cancer and steroid hormone study.
Claus, E. B., RISCH, N. J., & Thompson, W. D. (1991) · PubMed · Cited by 911
Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients With Early-Onset Breast Cancer
Peto, J., Collins, N., Barfoot, R., Seal, S., Warren, W., Rahman, N., Easton, D. F., Evans, C., Deacon, J., & Stratton, M. R. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.11.943 · Cited by 873
Lakhani, S. R., van de Vijver, M. J., Jacquemier, J., Anderson, T. J., Osin, P. P., McGuffog, L., & Easton, D. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.023 · Cited by 823
Frank, T. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1480 · Cited by 812
Estimating African American Admixture Proportions by Use of Population-Specific Alleles
Parra, E. J., Marcini, A., Akey, J., Martinson, J., Batzer, M. A., Cooper, R., Forrester, T., Allison, D. B., Deka, R., Ferrell, R. E., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/302148 · Cited by 771 · cited 1×
“Additionally, modern descendants from these groups carry genetic admixtures of roughly 20% non-African origi”
BackgroundAshkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
Roa, B. B., Boyd, A. A., Volcik, K., & Richards, C. S. (1996) · Nature Genetics · doi:10.1038/ng1096-185 · Cited by 770
Determining Carrier Probabilities for Breast Cancer–Susceptibility Genes BRCA1 and BRCA2
Parmigiani, G., Berry, D. A., & Aguilar, O. (1998) · The American Journal of Human Genetics · doi:10.1086/301670 · Cited by 753
Systematics and the Origin of Species from the View-Point of a Zoologist
S., W. L., & Mayr, E. (1943) · The Geographical Journal · doi:10.2307/1790142 · Cited by 748
Lakhani, S. R., Jacquemier, J., Sloane, J. P., Gusterson, B. A., Anderson, T. J., van de Vijver, M. J., Farid, L. M., Venter, D., Antoniou, A., Storfer-Isser, A., et al. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.15.1138 · Cited by 707
Genetic traces of ancient demography
Harpending, H. C., Batzer, M. A., Gurven, M., Jorde, L. B., Rogers, A. R., & Sherry, S. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1961 · Cited by 674
Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast Cancer
Walsh, T., Casadei, S., Coats, K. H., Swisher, E., Stray, S. M., Higgins, J., Roach, K. C., Mandell, J., Lee, M. K., Ciernikova, S., et al. (2006) · JAMA · doi:10.1001/jama.295.12.1379 · Cited by 666
Systematics and the Origin of Species from the Viewpoint of a Zoologist
Schmidt, K. P., & Mayr, E. (1943) · Copeia · doi:10.2307/1438628 · Cited by 660
(2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1407 · Cited by 604
Unusual case of Smith‐Lemli‐Opitz syndrome “type II”
Seller, M. J., Russell, J., & Tint, G. S. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320560305 · Cited by 585
BRCA1 dysfunction in sporadic basal-like breast cancer
Turner, N. C., Reis-Filho, J. S., Russell, A. M., Springall, R. J., Ryder, K., Steele, D., Savage, K., Gillett, C. E., Schmitt, F. C., Ashworth, A., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210014 · Cited by 573
Frank, T. S., Deffenbaugh, A. M., Reid, J. E., Hulick, M., Ward, B. E., Lingenfelter, B., Gumpper, K. L., Scholl, T., Tavtigian, S. V., Pruss, D. R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.6.1480 · Cited by 558
A faux 3′-UTR promotes aberrant termination and triggers nonsense- mediated mRNA decay
Amrani, N., Ganesan, R., Kervestin, S., Mangus, D. A., Ghosh, S., & Jacobson, A. (2004) · Nature · doi:10.1038/nature03060 · Cited by 532
Thorlacius, S., Olafsdottir, G., Tryggvadottir, L., Neuhausen, S., Jonasson, J. G., Tavtigian, S. V., Tulinius, H., Ögmundsdottir, H. M., & Eyfjörd, J. E. (1996) · Nature Genetics · doi:10.1038/ng0596-117 · Cited by 525
Jorde, L. B., Watkins, W. S., Bamshad, M. J., Dixon, M. E., Ricker, C. E., Seielstad, M. T., & Batzer, M. A. (2000) · The American Journal of Human Genetics · doi:10.1086/302825 · Cited by 516
Berry, D. A., Iversen, E. S., Gudbjartsson, D. F., Hiller, E. H., Garber, J. E., Peshkin, B. N., Lerman, C., Watson, P., Lynch, H. T., Hilsenbeck, S. G., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.05.121 · Cited by 505
Population genetics of BRCA1 and BRCA2.
Szabo, C. I., & King, M. (1997) · Europe PMC (PubMed Central) · Cited by 500
Gayther, S. A., Warren, W., Mazoyer, S., Russell, P. A., Harrington, P. A., Chiano, M., Seal, S., Hamoudi, R., van Rensburg, E. J., Dunning, A. M., et al. (1995) · Nature Genetics · doi:10.1038/ng1295-428 · Cited by 496
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes
Antoniou, A. C., Pharoah, P. D. P., McMullan, G., Day, N. E., Stratton, M. R., Peto, J., Ponder, B. J., & Easton, D. F. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600008 · Cited by 495
Variation in Cancer Risks, by Mutation Position, in BRCA2 Mutation Carriers
Thompson, D., & Easton, D. (2001) · The American Journal of Human Genetics · doi:10.1086/318181 · Cited by 489
The BOADICEA model of genetic susceptibility to breast and ovarian cancer
Antoniou, A. C., Pharoah, P. P. D., Smith, P., & Easton, D. F. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602175 · Cited by 467
Trends in Breast Cancer by Race and Ethnicity
Ghafoor, A., Jemal, A., Ward, E., Cokkinides, V., Smith, R., & Thun, M. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.6.342 · Cited by 451
Gayther, S. A., Mangion, J., Russell, P., Seal, S., Barfoot, R., Ponder, B. A. J., Stratton, M. R., & Easton, D. (1997) · Nature Genetics · doi:10.1038/ng0197-103 · Cited by 442
Schrag, D., Kuntz, K. M., Garber, J. E., & Weeks, J. C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362022 · Cited by 435
Armstrong, K. (2005) · JAMA · doi:10.1001/jama.293.14.1729 · Cited by 432
Genetic analysis of African populations: human evolution and complex disease
Tishkoff, S. A., & Williams, S. M. (2002) · Nature Reviews Genetics · doi:10.1038/nrg865 · Cited by 427
Outcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in BRCA Mutation Carriers
Scheuer, L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1260 · Cited by 404
Warner, E., Foulkes, W., Goodwin, P., Meschino, W., Blondal, J., Paterson, C., Ozcelik, H., Goss, P., Allingham-Hawkins, D., Hamel, N., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.14.1241 · Cited by 390
Cancer Risks in Two Large Breast Cancer Families Linked to BRCA2 on Chromosome 13q12‐13
Easton, D. F., Steele, L., Fields, P., Ormiston, W., Averill, D., Daly, P. A., McManus, R., Neuhausen, S. L., Ford, D., Wooster, R., et al. (1997) · The American Journal of Human Genetics · doi:10.1086/513891 · Cited by 387
Whittemore, A. S., Gong, G. D., & Itnyre, J. (1997) · PubMed · Cited by 383
Lykke-Andersen, J., Shu, M.-D., & Steitz, J. A. (2001) · Science · doi:10.1126/science.1062786 · Cited by 381
Shattuck-Eidens, D. (1997) · JAMA · doi:10.1001/jama.1997.03550150046034 · Cited by 374
Malone, K. E., Daling, J. R., Doody, D. R., Hsu, L., Bernstein, L., Coates, R. J., Marchbanks, P. A., Simon, M. S., McDonald, J. A., Norman, S. A., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0503 · Cited by 373
BRCA2 germline mutations in male breast cancer cases and breast cancer families
Couch, F. J., Farid, L. M., DeShano, M. L., Tavtigian, S. V., Calzone, K., Campeau, L., Peng, Y., Bogden, B., Chen, Q., Neuhausen, S., et al. (1996) · Nature Genetics · doi:10.1038/ng0596-123 · Cited by 363
Abeliovich, D., Kaduri, L., Lerer, I., Weinberg, N., Amir, G., Sagi, M., Zlotogora, J., Heching, N. I., & Peretz, T. (1997) · Europe PMC (PubMed Central) · Cited by 357
Population-based study of risk of breast cancer in carriers of BRCA2 mutation
Thorlacius, S., Struewing, J. P., Hartage, P., Olafsdottir, G. H., Sigvaldason, H., Tryggvadottir, L., Wacholder, S., Tulinius, H., & Eyfjörd, J. E. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03300-5 · Cited by 348
Newman, B. (1998) · JAMA · doi:10.1001/jama.279.12.915 · Cited by 345
Neuhausen, S. L., Godwin, A. K., Gershoni-Baruch, R., Schubert, E., Garber, J., Stoppa-Lyonnet, D., Olah, E., Csokay, B., Serova, O., Lalloo, F., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301885 · Cited by 335
Domchek, S. M., Friebel, T. M., Neuhausen, S. L., Wagner, T., Evans, G., Isaacs, C., Garber, J. E., Daly, M. B., Eeles, R., Matloff, E., et al. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70585-x · Cited by 327
Self-citationShattuck-Eidens, D. M. (1995) · JAMA · doi:10.1001/jama.273.7.535 · Cited by 327
Characterization of BRCA1 and BRCA2 Mutations in a Large United States Sample
Chen, S., Iversen, E. S., Friebel, T., Finkelstein, D., Weber, B. L., Eisen, A., Peterson, L. E., Schildkraut, J. M., Isaacs, C., Peshkin, B. N., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.6772 · Cited by 317
Levy‐Lahad, E., Catane, R., Eisenberg, S., Kaufman, B., Hornreich, G., Lishinsky, E., Shohat, M., Weber, B., Beller, U., Lahad, A., et al. (1997) · Europe PMC (PubMed Central) · Cited by 316
How many more breast cancer predisposition genes are there?
Easton, D. F. (1999) · Breast Cancer Research · doi:10.1186/bcr6 · Cited by 315
BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer
Moslehi, R., Chu, W., Karlan, B., Fishman, D., Risch, H., Fields, A., Smotkin, D., Ben-David, Y., Rosenblatt, J., Russo, D., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/302853 · Cited by 314
Hogervorst, F. B. L., Nederlof, P. M., Gille, J. J. P., McElgunn, C. J., Grippeling, M., Pruntel, R., Regnerus, R., van Welsem, T., van Spaendonk, R., Menko, F. H., et al. (2003) · PubMed · Cited by 314
Study of a single BRCA2 mutation with high carrier frequency in a small population.
Thorlacius, S., Sigurðsson, S., Bjarnadóttir, H., Ólafsdóttir, G. H., Jonasson, J. G., Tryggvadóttír, L., Tulinius, H., & Je, E. (1997) · Europe PMC (PubMed Central) · Cited by 294
Antoniou, A. C., Pharoah, P. D. P., McMullan, G., Day, N. E., Ponder, B. A. J., & Easton, D. (2001) · Genetic Epidemiology · doi:10.1002/gepi.1014 · Cited by 289
Mutations and Polymorphisms in the familial early-onset breast cancer (BRCA1) gene
Couch, F. J., Weber, B. L., & Core, B. C. I. (1996) · Human Mutation · doi:10.1002/humu.1380080102 · Cited by 285
Breast cancer in sub‐Saharan Africa: How does it relate to breast cancer in African‐American women?
Fregene, A., & Newman, L. A. (2005) · Cancer · doi:10.1002/cncr.20978 · Cited by 282
Hopper, J. L., Southey, M. C., Dite, G. S., Jolley, D. J., Giles, G. G., McCredie, M. R. E., Easton, D. F., & Venter, D. J. (1999) · PubMed · Cited by 260
Armes, J. E., Egan, A. J. M., Southey, M. C., Dite, G. S., McCredie, M. R. E., Giles, G. G., Hopper, J. L., & Venter, D. J. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981201)83:11<2335::aid-cncr13>3.0.co;2-n · Cited by 259
Nanda, R., Schumm, L. P., Cummings, S., Fackenthal, J. D., Sveen, L., Ademuyiwa, F., Cobleigh, M., Esserman, L., Lindor, N. M., Neuhausen, S. L., et al. (2005) · JAMA · doi:10.1001/jama.294.15.1925 · Cited by 250
Self-citationmtDNA and the Origin of the Icelanders: Deciphering Signals of Recent Population History
Helgason, A., Sigurðardóttir, S., Gulcher, J. R., Ward, R., & Stefánsson, K. (2000) · The American Journal of Human Genetics · doi:10.1086/302816 · Cited by 250
Loman, N., Johannsson, O., Kristoffersson, U., Olsson, H., & Borg, A. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.16.1215 · Cited by 248
Perrin-Vidoz, L. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.23.2805 · Cited by 246
Shattuck-Eidens, D. (1995) · JAMA · doi:10.1001/jama.1995.03520310033026 · Cited by 246
Linkage disequilibrium mapping in isolated populations: The example of Finland revisited
de la Chapelle, A., & Wright, F. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12416 · Cited by 243
Reconstructing human origins in the genomic era
Garrigan, D., & Hammer, M. F. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1941 · Cited by 240
Outcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in BRCA Mutation Carriers
Scheuer, L., Kauff, N., Robson, M., Kelly, B., Barakat, R., Satagopan, J., Ellis, N., Hensley, M., Boyd, J., Borgen, P., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.5.1260 · Cited by 239
Armes, J. E., Trute, L., White, D., Southey, M. C., Hammet, F., Tesoriero, A. A., Hutchins, A., Dite, G. S., McCredie, M. R. E., Giles, G. G., et al. (1999) · PubMed · Cited by 236
The Prevalence of Common BRCA1 and BRCA2 Mutations among Ashkenazi Jews
Hartge, P., Struewing, J. P., Wacholder, S., Brody, L. C., & Tucker, M. A. (1999) · The American Journal of Human Genetics · doi:10.1086/302320 · Cited by 226
High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients.
Jóhannesdóttir, G., Guðmundsson, J., Bergþorsson, J. Þ., Arason, A., Agnarsson, B. A., Eiríksdóttir, G., Johannsson, O. T., Borg, Å., Ingvarsson, S., Easton, D. F., et al. (1996) · PubMed · Cited by 223
Larger Genetic Differences Within Africans Than Between Africans and Eurasians
Yu, N., Chen, F.-C., Ota, S., Jorde, L. B., Pamilo, P., Patthy, L., Ramsay, M., Jenkins, T., Shyue, S.-K., & Li, W.-H. (2002) · Genetics · doi:10.1093/genetics/161.1.269 · Cited by 221
Fodor, F. H., Weston, A., Bleiweiss, I. J., McCurdy, L. D., Walsh, M. M., Tartter, P. I., Brower, S. T., & Eng, C. M. (1998) · The American Journal of Human Genetics · doi:10.1086/301903 · Cited by 220
The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan, J. M., Offit, K., Foulkes, W. D., Robson, M. E., Wacholder, S., Eng, C. M., Karp, S. E., & Begg, C. B. (2001) · PubMed · Cited by 218
Haplotype Trees and Modern Human Origins
Templeton, A. R. (2005) · American Journal of Physical Anthropology · doi:10.1002/ajpa.20351 · Cited by 212
Differential Contributions of BRCA1 and BRCA2 to Early-Onset Breast Cancer
Krainer, M., Silva-Arrieta, S., FitzGerald, M. G., Shimada, A., Ishioka, C., Kanamaru, R., MacDonald, D. J., Unsal, H., Finkelstein, D. M., Bowcock, A., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362003 · Cited by 210
Syrjakoski, K. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1529 · Cited by 197
A high proportion of founder BRCA1 mutations in Polish breast cancer families
Górski, B., Jakubowska, A., Huzarski, T., Byrski, T., Gronwald, J., Grzybowska, E., Mackiewicz, A., Stawicka, M., Bębenek, M., Sorokin, D., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20162 · Cited by 194
Montagna, M. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg120 · Cited by 183
Rubin, S. C., Blackwood, M. A., Bandera, C., Behbakht, K., Benjamin, I., Rebbeck, T. R., & Boyd, J. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70476-4 · Cited by 179
Breast cancer genetics in African Americans
Olopade, O. I., Fackenthal, J. D., Dunston, G., Tainsky, M. A., Collins, F., & Whitfield-Broome, C. (2003) · Cancer · doi:10.1002/cncr.11019 · Cited by 175
Self-citationWei, M., Grushko, T. A., Dignam, J., Hagos, F., Nanda, R., Sveen, L., Xu, J., Fackenthal, J., Tretiakova, M., Das, S., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1277 · Cited by 170
Self-citationDíez, O., Osorio, A., Durán, M., Martinez-Ferrandis, J. I., Hoya, M. D. L., Salazar, R., Vega, A., Campos, B., Rodríguez-López, R., Velasco, E., et al. (2003) · Human Mutation · doi:10.1002/humu.10260 · Cited by 170
Schubert, E. L., Lee, M. K., Mefford, H. C., ARGONZA, R. H., Morrow, J. E., Hull, J., Dann, J. L., & King, M. (1997) · PubMed · Cited by 166
Germline BRCA1 185delAG mutations in Jewish women with breast cancer
Offit, K., McGuire, P., Schluger, A. E., Hampel, H., Brown, K., Gilewski, T. A., Norton, L., Swensen, J. J., Neuhausen, S. L., Skolnick, M. H., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91484-1 · Cited by 166
The Matrilineal Ancestry of Ashkenazi Jewry: Portrait of a Recent Founder Event
Behar, D. M., Metspalu, E., Kivisild, T., Achilli, A., Hadid, Y., Tzur, S., Pereira, L., Amorim, A., Quintana-Murci, L., Majamaa, K., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/500307 · Cited by 160
Contribution of BRCA1 and BRCA2 Mutations to Breast and Ovarian Cancer in Pakistan
Liede, A., Malik, I. A., Aziz, Z., Rios, P. D. L., Kwan, E., & Narod, S. A. (2002) · The American Journal of Human Genetics · doi:10.1086/342506 · Cited by 159
Unger, M. A., Nathanson, K. L., Calzone, K., Antin-Ozerkis, D. E., Shih, H. A., Martin, A., Lenoir, G., Mazoyer, S., & Weber, B. L. (2000) · The American Journal of Human Genetics · doi:10.1086/303076 · Cited by 157
Mann, G. J., Thorne, H., Balleine, R. L., Butow, P. N., Clarke, C. L., Edkins, E., Evans, G. M., Fereday, S., Haan, E., Gattas, M. R., et al. (2006) · Breast Cancer Research · doi:10.1186/bcr1377 · Cited by 152
Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan, J. M., Boyd, J. A., Kauff, N. D., Robson, M. E., Scheuer, L., Narod, S. A., & Offit, K. (2002) · PubMed · Cited by 152
Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family.
Swensen, J., Hoffman, M. D., Skolnick, M., & Neuhausen, S. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.9.1513 · Cited by 152
Risk of Endometrial Carcinoma Associated with BRCA Mutation
Levine, D. A., Lin, O., Barakat, R. R., Robson, M. E., McDermott, D. A., Cohen, L., Satagopan, J. M., Offit, K., & Boyd, J. A. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2000.6082 · Cited by 144
Antoniou, A. C., Pharoah, P. D. P., Narod, S. A., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Olsson, H. L., Johannsson, O. T., Borg, Å., Pasini, B., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.024133 · Cited by 141
Kramer, J. L., Velazquez, I. A., Chen, B. E., Rosenberg, P. S., Struewing, J. P., & Greene, M. H. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.9199 · Cited by 135
Tryggvadóttír, L., Sigvaldason, H., Ólafsdóttir, G. H., Jonasson, J. G., Jónsson, Þ., Tulinius, H., & Eyfjord, J. E. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj012 · Cited by 131
Breast cancer predisposing alleles in Poland
Górski, B., Cybulski, C., Huzarski, T., Byrski, T., Gronwald, J., Jakubowska, A., Stawicka, M., Grodecka-Gazdecka, S., Szwiec, M., Urbański, K., et al. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-1409-1 · Cited by 128
Human demographic history: refining the recent African origin model
Excoffier, L. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00350-7 · Cited by 128
Schwartz, M. D., Kaufman, E. A., Peshkin, B. N., Isaacs, C. J., Hughes, C., DeMarco, T. A., Finch, C., & Lerman, C. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.088 · Cited by 121
Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients.
Choi, D., Lee, M. H., Bale, A., Carter, D., & Haffty, B. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.179 · Cited by 115
de Sanjosé, S., Léoné, M., Berez, V., Izquierdo, Á., Font, R., Brunet, J., Louat, T., Vilardell, L., Borràs, J., Viladiu, P., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11271 · Cited by 114
MtDNA evidence for a genetic bottleneck in the early history of the Ashkenazi Jewish population
Behar, D. M., Hammer, M. F., Garrigan, D., Villems, R., Bonné, B., Richards, M. B., Gurwitz, D., Rosengarten, D., Kaplan, M. E., DellaPergola, S., et al. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201156 · Cited by 108
Contribution of germline BRCA1 and BRCA2sequence alterations to breast cancer in Northern India
Saxena, S., Chakraborty, A., Kaushal, M., Kotwal, S. A., Bhatanager, D., Mohil, R. S., Chintamani, C., Aggarwal, A. K., Sharma, V. K., Sharma, P. C., et al. (2006) · BMC Medical Genetics · doi:10.1186/1471-2350-7-75 · Cited by 103
Assessing BRCA Carrier Probabilities in Extended Families
Barcenas, C. H., Hosain, G. M., Arun, B. K., Zong, J., Zhou, X., Chen, J., Cortada, J. M., Mills, G. B., Tomlinson, G. E., Miller, A. R., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2368 · Cited by 100
Mazoyer, S. (2000) · The American Journal of Human Genetics · doi:10.1086/302974 · Cited by 99
Southey, M., Tesoriero, A., Andersen, C. R., Jennings, K. M., Brown, S., Dite, G., Jenkins, M., Osborne, R., Maskiell, J., Porter, L., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690008 · Cited by 98
Kauff, N. D., Pérez‐Segura, P., Robson, M. E., Scheuer, L., Siegel, B., Schluger, A. E., Rapaport, B., Frank, T. S., Nafa, K., Ellis, N. A., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.8.611 · Cited by 94
One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations
Malander, S., Ridderheim, M., Måsbäck, A., Loman, N., Kristoffersson, U., Olsson, H. L., Nilbert, M. C., & Borg, Å. (2003) · European Journal of Cancer · doi:10.1016/j.ejca.2003.09.016 · Cited by 92
Hereditary ovarian cancer in Poland
Menkiszak, J., Gronwald, J., Górski, B., Jakubowska, A., Huzarski, T., Byrski, T., Foszczyńska‐Kłoda, M., Haus, O., Janiszewska, H., Ratajska, M., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11338 · Cited by 88
The mutational load due to detrimental genes in man.
Morton, N. E. (1960) · PubMed · Cited by 84
Matsushima, M., Kobayashi, K., Eml, M., et al. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.10.1953 · Cited by 81
Simard, J., Dumont, M., Moisan, A.-M., Gaborieau, V., Vézina, H., Durocher, F., Chiquette, J., Plante, M., Avard, D. M., Bessette, P., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.044388 · Cited by 81
Comparison of DNA- and RNA-Based Methods for Detection of TruncatingBRCA1 Mutations
Andrulis, I. L., Anton‐Culver, H., Beck, J. C., Bove, B. A., Boyd, J. A., Buys, S. S., Godwin, A. K., Hopper, J. L., Li, F., Neuhausen, S. L., et al. (2002) · Human Mutation · doi:10.1002/humu.10097 · Cited by 77
Haffty, B., Silber, A., Matloff, E., Chung, J. Y., & Lannin, D. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.034744 · Cited by 74
Racial differences in genetic factors associated with breast cancer
Ademuyiwa, F. O., & Olopade, O. I. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1022259901319 · Cited by 71
Self-citationDoes nonsense-mediated mRNA decay explain the ovarian cancer cluster region of the BRCA2 gene?
Ware, M. D., DeSilva, D., Sinilnikova, O. M., Stoppa‐Lyonnet, D., Tavtigian, S. V., & Mazoyer, S. (2005) · Oncogene · doi:10.1038/sj.onc.1209033 · Cited by 68
Large genomic deletions inactivate the BRCA2 gene in breast cancer families
Agata, S., Palma, M. D., Callegaro, M., Scaini, M. C., Menin, C., Ghiotto, C., Nicoletto, O., Zavagno, G., Chieco-Bianchi, L., D’Andrea, E., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.032789 · Cited by 66
Testing for BRCA1 mutations: a cost-effectiveness analysis
Sevilla, C., Moatti, J., Julian-reynier, C., Eisinger, F., Stoppa-Lyonnet, D., Paillerets, B., & Sobol, H. (2002) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200854 · Cited by 66
Sobol, H., Stoppa‐Lyonnet, D., Paillerets, B. B., Peyrat, J. P., Kerangueven, F., Janin, N., Noguchi, T., Eisinger, F., Guinebretière, J. M., Jacquemier, J. D., et al. (1996) · PubMed · Cited by 64
Rafnar, Þ., Benediktsdóttir, K. R., Eldon, B., Gestsson, T., Saemundsson, H., Olafsson, K., Salvarsdottir, A., Steingrı́msson, E., & Thorlacius, S. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.09.008 · Cited by 62
The ?portrait? of hereditary breast cancer
Lacroix, M., & Leclercq, G. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-2172-4 · Cited by 62
Bergman, A., Einbeigi, Z., Olofsson, U., et al. (2001) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200704 · Cited by 58
BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case–control study
Bjørge, T., Lie, A. K., Hovig, E. J., Gislefoss, R. E., Hansen, S., Jellum, E., Langseth, H., Nustad, K., Tropé, C. G., & Dørum, A. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602199 · Cited by 57
Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations
Marroni, F., Aretini, P., D’Andrea, E., Caligo, M. A., Cortesi, L., Viel, A., Ricevuto, E., Montagna, M., Cipollini, G., Ferrari, S., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.013623 · Cited by 57
Hendrickson, B. C., Judkins, T., Ward, B. D., et al. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20189 · Cited by 56
Mullineaux, L. G., Castellano, T. M., Shaw, J. J., Axell, L., Wood, M. E., Diab, S., Klein, C., Sitarik, M. A., Deffenbaugh, A. M., & Graw, S. L. (2003) · Cancer · doi:10.1002/cncr.11533 · Cited by 54
BRCA2 germ-line mutations in Spanish male breast cancer patients
Dı́ez, O., Cortés, J. M., Domènech, M., et al. (2000) · Annals of Oncology · doi:10.1023/a:1008339009528 · Cited by 50
Bonadona, V., Sinilnikova, O. M., Chopin, S., Antoniou, A. C., Mignotte, H., Mathevet, P., Bremond, A. G., Martin, A., Bobin, J.-Y., Romestaing, P., et al. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20199 · Cited by 49
Constraints for genetic association studies imposed by attributable fraction and familial risk
Hemminki, K., & Bermejo, J. L. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl182 · Cited by 47
Germline BRCA2 mutations in men with breast cancer
Mavraki, E., Gray, I., Bishop, D. T., et al. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.574 · Cited by 46
Genetic structure in four West African population groups
Adeyemo, A., Chen, G., Chen, Y., & Rotimi, C. N. (2005) · BMC Genetics · doi:10.1186/1471-2156-6-38 · Cited by 43
Zelada-Hedman, M., Arver, B. W., Claro, A., Chen, J., Werelius, B., Kok, H. S., Sandelin, K., Håkansson, S., Andersen, T. I., Borg, Å., et al. (1997) · PubMed · Cited by 41
Campos, B., Dı́ez, O., Domènech, M., Baena, M., Balmañà, J., Sanz, J., Ramírez, A., Alonso, C., & Baiget, M. (2003) · Human Mutation · doi:10.1002/humu.9176 · Cited by 39
Tobias, D. H., Eng, C. M., McCurdy, L. D., Kalir, T., Mandelli, J., Dottino, P., & Cohen, C. J. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5848 · Cited by 38
Martínez‐Ferrandis, J. I., Vega, A. I., Chirivella, I., Marín-García, P., Insa, A., Lluch, A. M., Carracedo, Á., Chaves, F. J., García-Conde, J., Cervantes, A. M. R., et al. (2003) · Human Mutation · doi:10.1002/humu.9188 · Cited by 33
BRCA1 variants in a family study of African-American and Latina women
McKean‐Cowdin, R., Feigelson, H. S., Xia, L. Y., Pearce, C. L., Thomas, D. C., Stram, D. O., & Henderson, B. E. (2005) · Human Genetics · doi:10.1007/s00439-004-1240-5 · Cited by 32
Polygenic Inherited Predisposition to Breast CancerPreprint
Ponder, B. A. J., Antoniou, A. C., Dunning, A. M., Easton, D. F., & Pharoah, P. D. P. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.029 · Cited by 31
BRCA1 Mutations in a Population-based Study of Breast Cancer in Stockholm County
Margolin, S., Werelius, B., Fornander, T., & Lindblom, A. (2004) · Genetic Testing · doi:10.1089/gte.2004.8.127 · Cited by 29
KANAAN, Y. M., Kpenu, E., Utley, K., Adams-Campbell, L. L., Dunston, G. M., Brody, L. C., & Broome, C. (2003) · Human Genetics · doi:10.1007/s00439-003-0999-0 · Cited by 20
Inherited susceptibility to breast and ovarian cancer
Diamond, T. M., Sutphen, R., Tabano, M., & Fiorica, J. V. (1998) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/00001703-199802000-00002 · Cited by 11
Mutational analysis of theBRCA1 gene in 30 Czech ovarian cancer patients
Zikán, M., Pohlreich, P., & Stříbrná, J. (2005) · Journal of Genetics · doi:10.1007/bf02715891 · Cited by 9
Cited by
The DNA Damage Response: Making It Safe to Play with Knives
Ciccia, A., & Elledge, S. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.019 · Cited by 4,368
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
Mavaddat, N., Peock, S., Frost, D., Ellis, S., Platte, R., Fineberg, E., Evans, D. G., Izatt, L., Eeles, R. A., Adlard, J., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt095 · Cited by 951
Breast Cancer Epidemiology and Risk Factors
ROJAS, K., & STUCKEY, A. (2016) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000239 · Cited by 576
Role of 5′‐ and 3′‐untranslated regions of mRNAs in human diseases
Chatterjee, S., & Pal, J. K. (2009) · Biology of the Cell · doi:10.1042/bc20080104 · Cited by 439
Resveratrol: Its Biologic Targets and Functional Activity
Pervaiz, S., & Holme, A. L. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2412 · Cited by 405
Metadata
- Authors
- Fackenthal, J. D., & Olopade, O. I.
- Venue
- Nature Reviews Cancer
- Published
- 2007-12
- Volume
- 7
- Issue
- 12
- Pages
- 937-948
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2067821218
- Cited by
- 488
- References
- 157
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.